Treatment Options For "Pre-Breast Cancer" Condition
Main Category: Breast CancerAlso Included In: Cancer / Oncology
Article Date: 23 Oct 2007 - 2:00 PDT
| Patient / Public: | ![]() |
4 (1 votes) |
| Healthcare Prof: | ![]() |
5 (1 votes) |
Breast specialists report no clear consensus on management of LCIS (lobular carcinoma in situ), generally considered a pre-cancerous condition that may indicate a patient's future risk of developing invasive breast cancer in either breast. Nearly 120 breast specialists responded to a survey conducted August 2007 on their practices regarding LCIS and pleomorphic LCIS.
Overall, about 70% of all respondents will usually or always recommend an excisional biopsy for LCIS. For patients with LCIS, only a small percentage of respondents would recommend mastectomy, sentinel node biopsy, or axillary lymph node dissection. The percentage of respondents recommending these procedures increases considerably for patients with pleomorphic LCIS, which is generally considered to be more aggressive.
The findings, published in the ASBD Advisor issue 2, 2007, is available online at http://www.asbd.org.
About the American Society of Breast Disease
The American Society of Breast Disease is the leading professional medical society in the United States to serve all physicians and allied professionals committed to and advocating an interdisciplinary team approach to breast cancer and disease management, prevention, early detection, treatment, and research. The Society advocates for improvements in breast healthcare. For information about the ASBD, visit the Society at http://www.asbd.org.
Visit our breast cancer section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/86346.php>
APA
http://www.medicalnewstoday.com/releases/86346.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





